Top Healthcare Technology Companies To Invest In 2015

Top Healthcare Technology Companies To Invest In 2015: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail C! orporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors' Opinion:

• [By Heather Long]

  Four of his picks -- LinkedIn (LNKD, Tech30), 3D Systems (DDD), Fidelity National (FNF) and Valeant Pharmaceuticals (VRX) -- did extremely well. Then there was Lululemon (LULU) -- the yoga apparel retailer whose shares sank more than 20%.

• [By Ben Levisohn]

  There’s no end in sight for Valeant’s (VRX) hostile takeover of Allergan (AGN)–but Sterne Agee’s Shibani Malhotra doesn’t see much downside regardless of the outcome. Malhotra explains:

  Bloomberg

  While we do not anticipate near-term resolution regarding Valeant's hostile bid, we continue to see limited downside risk for shareholders as it is clear that Valeant is determined to acquire Allergan, and if required, is willing to increase its bid even further. In addition, we are confident that Allergan management will either generate a strategy to drive greater value than a merger will deliver, or will negotiate a better price with Valeant.

  Shares of Allergan have gained 2.1% to $171.02 at 1:51 p.m. today, while Valeant has risen 1% to $132.58.

• [By Selena Maranjian]

  For example, consider Lone Pine Capital, founded by Steve Mandel in 1997. Lone Pine is one of the biggest hedge fund companies, and it has reportedly outperformed the S&P 500 handily since inception. Its reportable stock portfolio totaled $23 billion in value as of March 31, 2014. According to its recently released 13F statement, Lone Pine established or added to positions in Jazz Pharmaceuticals plc (NASDAQ: JAZZ  ) , SouFun Holdings Ltd (NYSE: SFUN  ) , and Valeant Pharmaceuticals International (NYSE: VRX  ) .

• [By Ben Levisohn]

  Stocks couldn’t fly high enough to get over ! yesterday! ’s record high*, as shares of McDonald’s (MCD) and Allergan (AGN) and Valeant Pharmaceuticals (VRX) dropped, while St. Jude Medical (STJ) and Stryker (SYK) have gained.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-healthcare-technology-companies-to-invest-in-2015.html